| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000243176.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000621109 |
Resistant |
| ENSG00000243176.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.036231952 |
Resistant |
| ENSG00000243176.1 |
Axitinib |
Lung squamous cell carcinoma |
0.018775147 |
Resistant |
